Clinical Trial Update: FINnish CardioVersion Study II

View source ↗

Summary

The FINnish CardioVersion Study II trial evaluating atrial fibrillation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Snippet

Sponsor: University of Turku | Conditions: Atrial Fibrillation | Status: COMPLETED